Register entry
Glaxo Wellcome Manufacturing Pte. Ltd
Data as of · How to read this entry
- Registered sites
- 0
- Active NDC listings
- 13
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
1313 active NDC listings: 13 bulk ingredient. By marketing category: BULK INGREDIENT 13.
| Dosage form | NDCs |
|---|---|
| powder | 13 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| glaxo wellcome manufacturing pte. ltd | 13 |
Catalogue
Marketed products
13| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Cabotegravir | powder | 52482-017BULK INGREDIENT |
| - | Cabotegravir Sodium | powder | 52482-018BULK INGREDIENT |
| - | Daprodustat | powder | 52482-020BULK INGREDIENT |
| - | dolutegravir sodium | powder | 52482-016BULK INGREDIENT |
| - | fluticasone furoate | powder | 52482-008BULK INGREDIENT |
| - | fluticasone propionate | powder | 52482-001BULK INGREDIENT |
| - | lamivudine | powder | 52482-003BULK INGREDIENT |
| - | naratriptan hydrochloride | powder | 52482-011BULK INGREDIENT |
| - | ondansetron | powder | 52482-019BULK INGREDIENT |
| - | salmeterol Xinafoate | powder | 52482-002BULK INGREDIENT |
| - | trametinib | powder | 52482-014BULK INGREDIENT |
| - | umeclidinium bromide | powder | 52482-012BULK INGREDIENT |
| - | vilanterol trifenatate | powder | 52482-009BULK INGREDIENT |
Compare
Other companies listing cabotegravir
- Aurobindo Pharma Limited6 sites · 1,453 NDC
- ViiV Healthcare Company0 sites · 26 NDC
Enquiry
Common questions
- Is Glaxo Wellcome Manufacturing Pte. Ltd FDA approved?
- Glaxo Wellcome Manufacturing Pte. Ltd holds no registered establishment of its own; 13 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Glaxo Wellcome Manufacturing Pte. Ltd make?
- 13 products are listed under Glaxo Wellcome Manufacturing Pte. Ltd in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.